Xealth receives investment from Philips, ResMed
By HME News Staff
Updated Fri March 29, 2019
SEATTLE - Xealth, a digital prescribing platform, has raised $11 million in a Series A financing round with new investments from healthcare companies like Philips, ResMed and McKesson.
The company says the investment will “fuel the expansion of Xealth's platform, better connecting patients and doctors.”
“With these new partners joining our existing investors and customers, Xealth will be serving virtually every sector of the healthcare industry—providers, payers, pharma, devices and supply chain,” said Mike McSherry, CEO of Xealth. “The Xealth platform is quickly becoming the preferred 'digital formulary.'”
Xealth allows clinicians to prescribe and monitor digital healthcare content, apps, devices and services from within their electronic health record charting interface, and to integrate the interaction into a health system's existing patient portal.
Originally incubated and launched at Providence St. Joseph Health in 2017, Xealth also works with UPMC, the Froedtert and the Medical College of Wisconsin health network, Baylor Scott and White, Duke and other health systems.
ResMed was an early partner of Xealth at Providence to help care for 40,000 patients using CPAP machines.
Xealth also made headlines last year when it was reportedly involved in a pilot program with Amazon and two hospital networks to allow doctors to recommend bundles of medical supplies and have them delivered to the homes of patients upon discharge.
Comments